73 Results for "

endocannabinoid

" in MedChemExpress (MCE) Product Catalog:
Products (73)

73 Results for "endocannabinoid" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-10865
CAS No.: 874902-19-9
Purity:  98.01%
Target:  

FAAH Autophagy

Research Areas:  

Neurological Disease

LY2183240 is a highly potent blocker of anandamide uptake (IC50= 270 pM; Ki=540 nM). LY2183240 is a potent, covalent inhibitor of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) with an IC50 of 12.4 nM. LY2183240 inactivates FAAH by carbamylation of the enzyme's serine nucleophile. LY2183240 also inhibits several other brain serine hydrolases with IC50s of 5.3, 0.09, 8.2 nM for MAG lipase, bh6 and KIAA1363, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10863
CAS No.: 94421-68-8
Purity:  ≥98.0%
Synonyms: AEA; Arachidonoyl ethanolamide
Anandamide is an endocannabinoid. Anandamide modulates both neuronal and immune functions through two protein-coupled cannabinoid receptors (CB1 and CB2). Anandamide can activate numerous other receptors like PPARS, TRPV1, and GPR18/GPR55. Anandamide also has potential anti-fungal and anti-inflammatory activities. Anandamide can be used for the research of Alzheimer’s disease (AD) and ulcerative colitis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-101388
CAS No.: 183718-77-6
Purity:  ≥99.0%
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

AM404, an inhibitor of endocannabinoid reuptake, blocks anandamide transport with IC50 values in the low micromolar range . AM404 is able to relax rat isolated hepatic arteries contracted with Phenylephrine, with a pEC50 value of 7.4 (corresponding to an EC50 of 0.04 μM). Neuroprotective Effect .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108613
CAS No.: 1515855-97-6
Purity:  99.55%
Target:  

MAGL

Research Areas:  

Neurological Disease Cancer

JJKK 048 is a highly selective and potent monoacylglycerol lipase (MAGL) inhibitor with IC50 values of 214 pM, 275 pM and 363 pM for human, rat, and mouse MAGL. JJKK 048 displays low cross-reactivity with other endocannabinoid targets. JJKK 048 can be used in the research of diseases such as cancer, neurodegenerative diseases, and pain .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-134545
CAS No.: 401941-73-9
Purity:  ≥99.0%
Synonyms: NALA
Research Areas:  

Cancer

N-Arachidonoyl-L-alanine is an endocannabinoid analog with anti-cancer effects. N- Arachidonoyl-L-alanine kills HNSCC cells through 5-LO-mediated ROS productio .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110004
CAS No.: 220556-69-4
Purity:  ≥96.0%
Synonyms: Arachidonyl-2-chloroethylamide
ACEA (short for arachidonyl-2'-chloroacetamide) is a synthetic organic compound that acts as an agonist of the cannabinoid receptor CB1. It is a chemical that affects the endocannabinoid system in the body, which regulates various physiological processes such as appetite, pain perception, mood, and memory .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103332
CAS No.: 179113-91-8
Purity:  98.90%
Synonyms: NA-Gly
N-Arachidonylglycine (NA-Gly), a carboxylic analog of the endocannabinoid anandamide (AEA), is a GPR18 agonist (EC50 = 44.5 nM). Unlike AEA, N-Arachidonylglycine has no activity at either CB1 or CB2 receptors. N-Arachidonylglycine inhibits GLYT2 (IC50 = 5.1 μM). N-Arachidonylglycine also is an effective activator of endometrial cell migration .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-133130
CAS No.: 1252765-13-1
Purity:  99.42%
Target:  

MAGL

Research Areas:  

Neurological Disease

JNJ-42226314, a chemical probe, is a competitive, highly selective and reversible non-covalent monoacylglycerol lipase (MAGL) inhibitor. JNJ-42226314 demonstrates dose-dependent enhancement of the major endocannabinoid 2-arachidonoylglycerol (2-AG) as well as efficacy in models of neuropathic and inflammatory pain .
loading...
    loading...
Cat. No.: HY-113015
CAS No.: 111-57-9
Purity:  98.68%
Stearoylethanolamide is an endocannabinoid-like compound with pro-apoptotic activity.
loading...
    loading...
Cat. No.: HY-N0313
CAS No.: 514-47-6
Euphol is a tetracyclic triterpene alcohol isolated from the sap of Euphorbia tirucalli with anti-mutagenic, anti-inflammatory and immunomodulatory effects, orally active. Euphol inhibits the monoacylglycerol lipase (MGL) activity via a reversible mechanism (IC50=315 nM). MGL inhibition in the periphery modulates the endocannabinoid system to block the development of inflammatory pain .
loading...
    loading...
Cat. No.: HY-152148
CAS No.: 1672691-50-7
Purity:  99.26%
Target:  

MAGL

Research Areas:  

Neurological Disease

JZP-MA-11 is a brain-penetrant positron emission tomography (PET) ligand targeting the brain endocannabinoid α/β-hydrolase domain 6 (ABHD6) enzyme. JZP-MA-11 selectively inhibits ABHD6 with an IC50 value of 126 nM. [18F]JZP-MA-11 has the potential for preclinical evaluation targeting the brain ABHD6 in mice and nonhuman primate (NHP) .
loading...
    loading...
Cat. No.: HY-W020035
CAS No.: 796963-91-2
Target:  

GPR55

Research Areas:  

Neurological Disease

L-α-lysophosphatidylinositol Soy sodium is an endogenous ligand of GPR55. L-α-lysophosphatidylinositol Soy sodium is an endogenous lysophospholipid and endocannabinoid neurotransmitter that belongs to the class of lysophospholipids .
loading...
    loading...
Cat. No.: HY-77491
CAS No.: 1010096-65-7
Target:  

FAAH MAGL

Research Areas:  

Neurological Disease

AM6701 is a potent FAAH/MAGL inhibitor (equipotent inhibitory IC50: 1.2 nM) with neuroprotective effects .
loading...
    loading...
Cat. No.: HY-120961
CAS No.: 85075-82-7
Synonyms: N-Ethyloleamide
Target:  

FAAH

Research Areas:  

Metabolic Disease

Oleoyl ethyl amide (N-Ethyloleamide) is a fatty acid amide hydrolase (FAAH) inhibitor. Oleoyl ethyl amide can counteract bladder overactivity .
loading...
    loading...
Cat. No.: HY-110206
CAS No.: 1245626-05-4
Purity:  99.32%
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

AM6545 is a highly selective, brain-free (peripherally active) CB1 receptor antagonist (Ki=1.7 nM). AM6545 inhibits endocannabinoid signaling by competitively antagonizing CB1 receptors, inhibiting CB1-mediated appetite stimulation and inflammatory responses without affecting cAMP levels. AM6545 significantly reduces food intake and body weight in mice, while improving metabolic syndrome-related renal impairment (such as proteinuria, fibrosis) and insulin resistance. AM6545 can be used in the study of obesity and its complications .
loading...
    loading...
Cat. No.: HY-113070
CAS No.: 150314-34-4
Purity:  ≥99.0%
Dihomo-γ-Linolenoyl Ethanolamide, an endocannabinoid, is a cannabinoid (CB) receptor agonist with Kis of 857 nM and 598 nM for human recombinant CB1 and CB2 receptors, respectively .
loading...
    loading...
Cat. No.: HY-125407
CAS No.: 126127-31-9
Purity:  95.9%
Synonyms: N-Palmitoyl serinol
Target:  

Cannabinoid Receptor

Research Areas:  

Inflammation/Immunology

Palmitoyl serinol (N-Palmitoyl serinol) is an analog of the endocannabinoid N-palmitoyl ethanolamine (PEA). Palmitoyl serinol improves the epidermal permeability barrier in both normal and inflamed skin .
loading...
    loading...
Cat. No.: HY-132310
CAS No.: 2135785-20-3
Purity:  99.91%
Target:  

MAGL

Research Areas:  

Neurological Disease

MAGL-IN-4 is an orally active, selective and reversible monoacylglycerol lipase (MAGL) inhibitor with an IC50 of 6.2 nM. MAGL-IN-4 can penetrate the blood-brain barrier (BBB). MAGL-IN-4 enhances endocannabinoid signaling mostly by the increase in the level of 2-AG via selective MAGL inhibition in the brain .
loading...
    loading...
Cat. No.: HY-101389
CAS No.: 157182-49-5
Synonyms: AM-356
Research Areas:  

Neurological Disease

(R)-Methanandamide (AM-356), an analog of the endocannabinoid ligand Anandamide, is a potent CB1 agonist with a Ki of 20 nM. (R)-Methanandamide also activates vanilloid (TRPV1) receptors .
loading...
    loading...
Cat. No.: HY-12790
CAS No.: 1429239-98-4
Purity:  99.83%
Synonyms: CB1-IN-1
Target:  

Cannabinoid Receptor

Research Areas:  

Metabolic Disease

BPRCB1184 is a peripherally restricted 1-type cannabinoid receptor (CB1) antagonist, whose activity is associated with the regulation of obesity-related endocannabinoid system. BPRCB1184 regulates the activity of the endocannabinoid system, promotes lipid mobilization, reduces triglyceride storage, improves glucose metabolism, decreases food intake and body weight, while enhances insulin resistance and improves blood lipid levels. BPRCB1184 can be used in obesity-related research .
loading...
    loading...